120
Participants
Start Date
November 26, 2019
Primary Completion Date
March 30, 2024
Study Completion Date
June 30, 2024
Human Mesenchymal Stromal Cells
Immediately prior to administration, the study product will be thawed and diluted 1:1 with reconstitution media (1:1 mix of 5% human serum albumin and 10% Dextran 40). Additional reconstitution media is added to a final product volume of 300 mL.
Cell Reconstitution Media
300 mL of reconstitution media (1:1 mix of 5% human serum albumin and 10% Dextran 40)
Vanderbilt University Medical Center, Nashville
Memorial Hermann Hospital - Texas Medical Center, Houston
Zuckerberg San Francisco General Hospital and Trauma Center, San Francisco
University of California San Francisco, San Francisco
University of California Davis Medical Center, Sacramento
Oregon Health & Science University, Portland
Harborview Medical Center, Seattle
United States Department of Defense
FED
Harborview Injury Prevention and Research Center
OTHER
Oregon Health and Science University
OTHER
Vanderbilt University Medical Center
OTHER
The University of Texas Health Science Center, Houston
OTHER
University of Minnesota
OTHER
Michael A. Matthay
OTHER